Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2020 / N 3

Хроническая обструктивная болезнь легких и гастроэзофагеальная рефлюксная болезнь
Э.Х. Анаев, Э.П. Яковенко

References

1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2017 Mar;195(5):557-82.
2. Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2020 report). Available from: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.1wms.pdf Accessed 2021 Feb 15.
3. Estores DS. Symptom predictability in gastroesophageal reflux disease and role of proton pump inhibitor test. Gastroenterology Clinics of North America 2014 Mar;43(1):27-38.
4. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. The American Journal of Gastroenterology 2013;108(3):308-28; quiz 329.
5. Yadlapati R, DeLay K. Proton pump ingibitor – refractory gastroesophageal reflux disease. Medical Clinics of North America 2019 Jan;103(1):15-27.
6. el-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014 Jun;63(6):871-80.
7. Peery AF, Crockett SD, Barritt AS, Dellon ES, Eluri S, Gangarosa LM, Jensen ET, Lund JL, Pasricha S, Runge T, Schmidt M, Shaheen NJ, Sandler RS. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology 2015 Dec;149(7):1731-41.e3.
8. Griffiths TL, Nassar M, Soubani AO. Pulmonary manifestations of gastroesophageal reflux disease. Expert Review of Respiratory Medicine 2020 Apr;14(8):1-9.
9. Khan HN, Suleman A, Ullah R, Abdullah A, Naz S. Gastro oesophageal reflux diseases in chronic obstructive pulmonary disease patients. Journal of Ayub Medical College, Abbottabad 2018 Jan-Mar;30(1):64-6.
10. Terada K, Muro S, Ohara T, Kudo M, Ogawa E, Hoshino Y, Hirai T, Niimi A, Chin K, Mishima M. Abnormal swallowing reflex and COPD exacerbations. Chest 2010 Feb;137(2):326-32.
11. Kim J, Lee JH, Kim Y, Kim K, Oh YM, Yoo KH, Rhee CK, Yoon HK, Kim YS, Park YB, Lee SW, Lee SD. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulmonary Medicine 2013 Aug;13:51.
12. Mokhlesi B. Clinical implications of gastroesophageal reflux disease and swallowing dysfunction in COPD. American Journal of Respiratory Medicine 2003;2(2):117-21.
13. Crowell MD, Zayat EN, Lacy BE, Schettler-Duncan A, Liu MC. The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study. Chest 2001 Oct;120(4):1184-9.
14. Areias V, Carreira S, Anciaes M, Pinto P, Bárbara C. Co-morbidities in patients with gold stage 4 chronic obstructive pulmonary disease. Revista Portuguesa de Pneumologia 2014 Jan-Feb;20(1):5-11.
15. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. The Lancet 2012 Apr;379(9823):1341-51.
16. el-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997 Sep;113(3):755-60.
17. Martinez CH, Okajima Y, Murray S, Washko GR, Martinez FJ, Silverman EK, Lee JH, Regan EA, Crapo JD, Curtis JL, Hatabu H, Han MK; COPDGene Investigators. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respiratory Research 2014 Jun;15(1):62.
18. Lee AL, Goldstein RS. Gastroesophageal reflux disease in COPD: links and risks. International Journal of Chronic Obstructive Pulmonary Disease 2015;10(1):1935-49.
19. Ates F, Vaezi MF. Approach to the patient with presumed extraoesophageal GERD. Best Practice & Research: Clinical Gastroenterology 2013 Jun;27(3):415-31.
20. Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H, Ino K, Horikoshi T, Sugiyama T, Toki M, Ohwada T, Mori M. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. Journal of Gastroenterology 2004 Sep;39(9):888-91.
21. Bredenoord AJ, Pandolfino JE, Smout AJ. Gastro-oesophageal reflux disease. The Lancet 2013 Jun;381(9881):1933-42.
22. Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. American Journal of Gastroenterology 1997 May;92(5):825-9.
23. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Annals of Internal Medicine 2004 Apr;140(7):518-27.
24. Shirai T, Mikamo M, Tsuchiya T, Shishido Y, Akita T, Morita S, Asada K, Fujii M, Suda T. Real-world effect of gastroesophageal reflux disease on cough-related quality of life and disease status in asthma and COPD. Allergology International 2015 Jan;64(1):79-83.
25. Mokhlesi B, Morris AL, Huang CF, Curcio AJ, Barrett TA, Kamp DW. Increased prevalence of gastroesophageal reflux symptoms in patients with COPD. Chest 2001 Apr;119(4):1043-8.
26. Benson VS, Müllerová H, Vestbo J, Wedzicha JA, Patel A, Hurst JR; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease. Respiratory Medicine 2015;109(9):1147-54.
27. Terada K, Muro S, Sato S, Haruna A, Marumo S, Kinose D, Ogawa E, Hoshino Y, Niimi A, Terada T, Mishima M. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax 2008 Nov;63(11):951-5.
28. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clinic Proceeding 1994 Jun;69(6):539-47.
29. García Rodríguez LA, Ruigomez A, Martin-Merino E, Johansson S, Wallander MA. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest 2008 Dec;134(6):1223-30.
30. Bor S, Kitapcioglu G, Solak ZA, Ertilav M, Erdinc M. Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease. Journal of Gastroenterology and Hepatology 2010 Feb;25(2):309-13.
31. Kamble NL, Khan NA, Kumar N, Nayak HK, Daga MK. Study of gastro-oesophageal reflux disease in patients with mild-to-moderate chronic obstructive pulmonary disease in India. Respirology (Carlton, Vic.) 2013 Apr;18(3):463-7.
32. Kim SW, Lee JH, Sim YS, Ryu YJ, Chang JH. Prevalence and risk factors for reflux esophagitis in patients with chronic obstructive pulmonary disease. Korean Journal of Internal Medicine 2014 Jul;29(4):466-73.
33. Kempainen RR, Savik K, Whelan TP, Dunitz JM, Herrington CS, Billings JL. High prevalence of proximal and distal gastroesophageal reflux disease in advanced COPD. Chest 2007 Jun;131(6):1666-71.
34. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002 Oct;57(10):847-52.
35. Rascon-Aguilar IE, Pamer M, Wludyka P, Cury J, Coultas D, Lambiase LR, Nahman NS, Vega KJ. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest 2006 Oct;130(4):1096-101.
36. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EFM, Wedzicha JA; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. The New England Journal of Medicine 2010 Sep;363(12):1128-38.
37. Takada K, Matsumoto S, Kojima E, Iwata S, Okachi S, Ninomiya K, Morioka H, Tanaka K, Enomoto Y. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire. Respiratory Medicine 2011 Oct;105(10):1531-6.
38. Casanova C, Baudet JS, del Valle Velasco M, Martin JM, Aguirre-Jaime A, de Torres JP, Celli BR. Increased gastro-oesophageal reflux disease in patients with severe COPD. The European Respiratory Journal 2004 Jun;23(6):841-5.
39. Lee AL, Button BM, Denehy L, Roberts SJ, Bamford TL, Ellis SJ, Mu FT, Heine RG, Stirling RG, Wilson JW. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis. Respirology (Carlton, Vic.) 2014 Feb;19(2):211-7.
40. Sakae TM, Pizzichini MM, Teixeira PJ, da Silva RM, Trevisol DJ, Pizzichini E. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. Jornal Brasileiro Pneumologia 2013 May-Jun;39(3):259-71.
41. Broers C, Tack J, Pauwels A. Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease. Alimentary Pharmacology & Therapeutics 2018 Jan;47(2):176-91.
42. Sweet MP, Patti MG, Hoopes C, Hays SR, Golden JA. Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax 2009 Feb;64(2):167-73.
43. Rogha M, Behravesh B, Pourmoghaddas Z. Association of gastroesophageal reflux disease symptoms with exacerbations of chronic obstructive pulmonary disease. Journal of Gastrointestinal and Liver Diseases 2010 Sep;19(3):253-6.
44. Tsai CL, Lin YH, Wang MT, Chien LN, Jeng C, Chian CF, Perng WC, Chiang CH, Chiou HY. Gastro-oesophageal reflux disease increases the risk of intensive care unit admittance and mechanical ventilation use among patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study. Critical Care 2015 May;19(1):110.
45. Wedzicha JA, Brill SE, Allinson JP, Donaldson GC. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Medicine 2013 Aug;11:181.
46. Hasanoglu HC, Yildirim Z, Hasanoglu A, Ozcan C, Gokirmak M, Koksal N, Kalkan S. Effects of ranitidine on pulmonary function tests of patients with chronic obstructive pulmonary disease. Pharmacological Research 2003 Jun;47(6):535-9.
47. Eryuksel E, Dogan M, Olgun S, Kocak I, Celikel T. Incidence and treatment results of laryngopharyngeal reflux in chronic obstructive pulmonary disease. European Archives of Oto-Rhino-Laryngology 2009 Aug;266(8):1267-71.
48. Sasaki T, Nakayama K, Yasuda H, Yoshida M, Asamura T, Ohrui T, Arai H, Araya J, Kuwano K, Yamaya M. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. Journal of the American Geriatrics Society 2009 Aug;57(8):1453-7.
49. Lee SW, Lien HC, Chang CS, Yeh HZ, Lee TY, Tung CF. The impact of acid-suppressing drugs to the patients with chronic obstructive pulmonary disease: a nationwide, population-based, cohort study. Journal of Research in Medical Sciences 2015 Mar;20(3):263-7.
50. Ingebrigtsen TS, Marott JL, Vestbo J, Nordestgaard BG, Hallas J, Lange P. Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease. Respirology (Carlton, Vic.) 2015 Jan;20(1):101-7.
51. Su VY, Liao HF, Perng DW, Chou YC, Hsu CC, Chou CL, Chang YL, Yen JC, Chen TJ, Chou TC. Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD. International Journal of Chronic Obstructive Pulmonary Disease 2018 Sep;13:2907-15.
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]